Innovations In Pharmacoepidemiology

  Innovations in pharmacoepidemiology are novel theories, apparatuses or procedures. Innovations are the implementation of better solutions that already exist which satisfy new needs, inarticulated needs or market requirements. It is capable of making goods, processes, services , technology, or innovative innovations more productive and readily accessible to consumers, governments , and society. Innovations are a innovative and original idea, as an essential new product that "breaks through" the market or culture. Answering the demanding questions asked of pharmacotherapy in the 21st century will require more reliance on the disciplines of pharmacoepidemiology and pharmacoeconomics. Pharmacoepidemiology can help assess patterns and appropriateness of drug utilisation, provide explanations for poor compliance, quantify the frequency and severity of side effects, and aid in the design and evaluation of interventions to improve drug use and outcomes. Pharmacoeconomics can help determine whether a new costlier product offers sufficient clinical advantage over its predecessors to justify the increased cost. Taken together, pharmacoepidemiology and pharmacoeconomics represent the next logical step in the evolution of medication assessment; their judicious deployment can help ensure both access to new medicines and innovation.  

High Impact List of Articles

Relevant Topics in Clinical